Status | Study |
RECRUITING |
Study Name: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics Condition: Biliary Tract Neoplasms Date: 2020-09-21 Interventions: According to the treatment dose approved by NMPA/FDA, evaluation will be conducted every 2 cycles until tumor progression or adverse events canno |
Recruiting |
Study Name: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers Condition: Biliary Tract Cancer Date: 2017-05-05 Interventions: Drug: Apatinib Apatinib 500mg, po, qd, every 4 weeks. |
Recruiting |
Study Name: Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) Condition: Radiation Therapy Cancer Cancer of Anus Date: 2017-04-24 |
Not yet recruiting |
Study Name: Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer Condition: Advanced or Metastatic Biliary Tract Cancer Date: 2017-04-21 Interventions: Drug: Varlitinib everyday |
Not yet recruiting |
Study Name: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) Condition: Biliary Tract Cancer Date: 2017-04-12 Interventions: Drug: Pembrolizumab (MK-3475) |
Not yet recruiting |
Study Name: FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions: Drug: Fluorouracil 5FU 400mg/m |
Not yet recruiting |
Study Name: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions: Drug: Pemetrexed 500 MG Pemetr |
Not yet recruiting |
Study Name: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer Condition: Biliary Tract Neoplasms Date: 2017-03-30 Interventions: Drug: Gemcitabine Gemcitabine |
Not yet recruiting |
Study Name: Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer Condition: Biliary Tract Cancer Date: 2017-03-16 Interventions: Drug: Varlitinib Varlitinib:30 |
Not yet recruiting |
Study Name: Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes Condition: Biliary Tract Cancer Date: 2017-03-16 Interventions: Drug: MK3475 anti-PD1 immunotherapy Other Name: Pemb |